BERNSTEIN, I. L. 1999. Disease management of drug hypersensitivity: a practice parameter: These parameters were developed by the joint task force on practice parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the joint Council of Allergy, Asthma and Immunology. McLean: American College of Allergy, Asthma and Immunology.
Citáce podľa APA (7th ed.)Bernstein, I. L. (1999). Disease management of drug hypersensitivity: a practice parameter: These parameters were developed by the joint task force on practice parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the joint Council of Allergy, Asthma and Immunology. American College of Allergy, Asthma and Immunology.
Citácia podle Chicago (17th ed.)Bernstein, I. Leonard. Disease Management of Drug Hypersensitivity: A Practice Parameter: These Parameters Were Developed by the Joint Task Force on Practice Parameters, Representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. McLean: American College of Allergy, Asthma and Immunology, 1999.
Citácia podľa MLA (8th ed.)Bernstein, I. Leonard. Disease Management of Drug Hypersensitivity: A Practice Parameter: These Parameters Were Developed by the Joint Task Force on Practice Parameters, Representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. American College of Allergy, Asthma and Immunology, 1999.
